Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 55.73B | 58.07B | 52.26B | 57.88B | 47.24B | 47.79B |
Gross Profit | 6.17B | 7.14B | 6.39B | 6.20B | 4.36B | 5.07B |
EBITDA | 2.49B | 3.61B | 3.21B | 3.14B | 1.74B | 2.18B |
Net Income | 1.42B | 2.31B | 1.67B | 1.65B | 788.13M | 1.05B |
Balance Sheet | ||||||
Total Assets | 41.86B | 45.16B | 37.63B | 39.70B | 32.63B | 30.98B |
Cash, Cash Equivalents and Short-Term Investments | 4.53B | 5.19B | 4.22B | 4.49B | 3.37B | 2.72B |
Total Debt | 9.19B | 9.37B | 6.14B | 4.99B | 2.80B | 2.90B |
Total Liabilities | 23.68B | 24.59B | 20.74B | 23.62B | 18.90B | 18.60B |
Stockholders Equity | 17.87B | 20.28B | 16.57B | 15.78B | 13.48B | 12.13B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -3.72B | 25.07M | -1.12B | 688.88M | 1.36B |
Operating Cash Flow | 0.00 | -687.33M | 1.74B | -506.50M | 1.67B | 2.07B |
Investing Cash Flow | 0.00 | -2.46B | -1.65B | -576.64M | -1.01B | -1.08B |
Financing Cash Flow | 0.00 | 4.06B | -562.00M | 1.89B | -253.68M | -1.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | ¥9.93B | 11.66 | 4.79% | 5.27% | -26.42% | ||
81 Outperform | ¥11.14B | 4.20 | 4.61% | 11.12% | 29.82% | ||
78 Outperform | ¥12.99B | 6.72 | 4.01% | -9.31% | 2.74% | ||
76 Outperform | ¥13.40B | 7.68 | 4.58% | 33.76% | ― | ||
72 Outperform | ¥9.89B | 10.74 | 4.63% | 6.79% | 34.45% | ||
70 Neutral | ¥13.76B | 8.74 | 3.70% | 32.17% | 298.59% | ||
58 Neutral | HK$13.95B | 4.43 | -3.01% | 7.31% | 3.67% | -54.16% |